the aid library

LIST OPTIONS

Filter

3971

Sort by:

Direction:

Download (2303)

View PDF (4734)

Workplace Pandemic Preparedness. Training Manual
recommended

Ministry of Health Ghana; NADMO Ghana GiZ Deutsche Gesellschaft für Internationale Zusammenarbeit (2013) C1

A training manual for identifying, assessing, preventing and controlling the risks of pandemics in the workplace. This training manual has been developed for both medical and non-medical personnel who may be called upon to lead emergency response, (eg epidemic outbreak, etc), ensure effective conta... more

Download (487)

View PDF (654)

Global Sexual and Reproductive Health Service Package for Men and Adolescent Boys

IPPF, UNFPA (2017)

The Global Sexual and Reproductive Health Service Package for Men and Adolescent Boys has been developed to support providers of sexual and reproductive health (SRH) services to increase the range and quality of services to meet the specific and diverse needs of men and adolescent boys. This package... more

Download (570)

View PDF (1296)

Management of severe malnutrition: a manual for physicians and other senior health workers

World Health Organization WHO (1999) C_WHO

This manual provides practical guidelines for the management of children with severe malnutrition. It seeks to promote the best available therapy so as to reduce the risk of death, shorten the length of time spent in hospital, and facilitate rehabilitation and full recovery. Emphasis is given to the... more

Download (8706)

View PDF (2647)

Guide Material for Medical Store Management Training
recommended

Community Development Medicinal Unit (2012) C_WHO

Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ... more

Download (341)

View PDF (616)

The Malawi Girls' Empowerment Through Education and Health Activity (ASPIRE): 2017 Performance Evaluation Report

Falconer-Stout, Z., K. Simmons, P. Godbole, S. Topolansky, R. Frischkorn, and L. Franco USAID (2018) C1

This external performance evaluation of the Malawi Girls’ Empowerment through Education and Health Activity (ASPIRE), conducted 2.5 years after ASPIRE began, establishes the activity’s progress against its objectives, proposes adaptations for the final year, and captures lessons for application ... more

Download (1647)

View PDF (2658)

Guidelines for the screening, care and treatment of persions with hepatitis C infection. Updated Version, April 2016
recommended

World Health Organization WHO (2016) C_WHO

The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen... more

Download (220)

View PDF (336)

Rwanda: MATERNAL, NEONATAL AND CHILD HEALTH NATIONAL STRATEGY JULY 2013- JUNE 2018

Ministry of Health, Rwanda & Rwanda Biomedical Centre (2013) C2

This document sets out Rwanda's Maternal, Neonatal Child Health (MNCH) national strategy (July 2013- June 2018). The MNCH strategy provides a framework for addressing maternal, neonatal and child health challenges currently facing Rwanda. It is an overarching strategy for scale up of the national re... more

Download (106)

View PDF (152)

We need to talk

Translators without Borders (2019) CC

Effective Ebola risk communication requires respect and transparency and remains as vital as ever. An assessment of changing communication needs and preferences in Beni, North Kivu. In the second year of the current Ebola outbreak response in the Democratic Republic of Congo (DRC), people at ris... more

Download (79)

View PDF (136)

WHO Regional Office for Europe advice on the use of experimental medicines for the treatment of COVID-19 patients

World Health Organization (Europe) (2020) C_WHO

9 April 2020 WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe... more

Download (139)

View PDF (174)

A practical guide for developing Child Friendly Spaces

UNICEF (2016) CC

This guide is designed to assist UNICEF staff and partners, in establishing and operating Child Friendly Spaces (CFS) in an emergency. It attempts to provide readers with the main principles of a CFS and the processes on how to establish one. The overall aim is to improve the standards and capac... more

Download (106)

View PDF (163)

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
recommended

World Health Organization WHO (2022) C_WHO

These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc... more

Download (172)

View PDF (153)

WHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment

World Health Organization WHO (2020) C_WHO

The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook... more

Download (124)

View PDF (166)

Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac

World Health Organization WHO (2022) C_WHO

These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. This document has been updat... more

Download (91)

View PDF (144)

Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm (28 October 2021), updated 15 March 2022

World Health Organization WHO (2022) C_WHO

These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. Th... more

Download (148)

View PDF (196)

Nurses and midwives: a vital resource for health

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

This European compendium was produced to provide operational examples of the new nursing and midwifery roles and new service delivery models currently being employed across the Region. The case studies directly relate to the priority areas in Health 2020 and exemplify the types of activities needed ... more

Download (190)

View PDF (245)

WHO recommendations on maternal and newborn care for a positive postnatal experience
recommended

World Health Organization WHO (2022) CC

This guideline aims to improve the quality of essential, routine postnatal care for women and newborns with the ultimate goal of improving maternal and newborn health and well-being. It recognizes a “positive postnatal experience” as a significant end point for all women giving birth and their n... more

Download (136)

View PDF (192)

WHO Guideline on self-care interventions for health and well-being, 2022 revision: executive summary
recommended

World Health Organization WHO (2022) C_WHO

A global shortage of an estimated 18 million health workers is anticipated by 2030, a record 130 million people are in need of humanitarian assistance, and there is the global threat of pandemics such as COVID-19. At least 400 million people worldwide lack access to the most essential health service... more

Download (93)

View PDF (330)

Assessing development assistance for child survival between 2000 and 2014: A multisectoral perspective

Lu, C.; A. Chu, Z. Li et al. PLOS One (2017) CC

The majority of Countdown countries did not reach the fourth Millennium Development Goal (MDG 4) on reducing child mortality, despite the fact that donor funding to the health sector has drastically increased. When tracking aid invested in child survival, previous studies have exclusively focused on... more

Download (239)

View PDF (322)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (16)

View PDF (55)

WHO consolidated guidelines on tuberculosis Module 1: prevention - tuberculosis preventive treatment, second edition

World Health Organisation (WHO) (2024) C_WHO

About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im... more

Workplace Pandemic Preparedness. Training Manual recommended

Guide Material for Medical Store Management Training recommended

Guidelines for the screening, care and treatment of persions with hepatitis C infection. Updated Version, April 2016 recommended

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) recommended

WHO recommendations on maternal and newborn care for a positive postnatal experience recommended

WHO Guideline on self-care interventions for health and well-being, 2022 revision: executive summary recommended

Workplace Pandemic Preparedness. Training Manual
recommended

Guide Material for Medical Store Management Training
recommended

Guidelines for the screening, care and treatment of persions with hepatitis C infection. Updated Version, April 2016
recommended

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
recommended

WHO recommendations on maternal and newborn care for a positive postnatal experience
recommended

WHO Guideline on self-care interventions for health and well-being, 2022 revision: executive summary
recommended